Comprehensive scientific data provide evidence that isolated phytochemicals or whole plant foods may beneficially modify carcinogenesis. The aim of this study was to evaluate the oncostatic activities of Rhus coriaria L. (sumac) using animal models (rat and mouse), and cell lines of breast carcinoma. R. coriaria (as a powder) was administered through the diet at two concentrations (low dose: 0.1% (w/w) and high dose: 1 % (w/w)) for the duration of the experiment in a syngeneic 4T1 mouse and chemically-induced rat mammary carcinoma models. After autopsy, histopathological and molecular analyses of tumor samples in rodents were performed. Moreover, in vitro analyses using MCF-7 and MDA-MB-231 cells were conducted. The dominant metabolites present in tested R. coriaria methanolic extract were glycosides of gallic acid (possible gallotannins). In the mouse model, R. coriaria at a higher dose (1%) significantly decreased tumor volume by 27% when compared to controls. In addition, treated tumors showed significant dose-dependent decrease in mitotic activity index by 36.5% and 51% in comparison with the control group. In the chemoprevention study using rats, R. coriaria at a higher dose significantly reduced the tumor incidence by 20% and in lower dose non-significantly reduced tumor frequency by 29% when compared to controls. Evaluations of the mechanism of oncostatic action using valid clinical markers demonstrated several positive alterations in rat tumor cells after the treatment with R. coriaria. In this regard, histopathological analysis of treated tumor specimens showed robust dose-dependent decrease in the ratio of high-/low-grade carcinomas by 66% and 73% compared to controls. In treated rat carcinomas, we found significant caspase-3, Bax, and Bax/Bcl-2 expression increases; on the other side, a significant down-regulation of Bcl-2, Ki67, CD24, ALDH1, and EpCam expressions and MDA levels. When compared to control specimens, evaluation of epigenetic alterations in rat tumor cells in vivo showed significant dose-dependent decrease in lysine methylation status of H3K4m3 and H3K9m3 and dose-dependent increase in lysine acetylation in H4K16ac levels (H4K20m3 was not changed) in treated groups. However, only in lower dose of sumac were significant decreases in the expression of oncogenic miR210 and increase of tumor-suppressive miR145 (miR21, miR22, and miR155 were not changed) observed. Finally, only in lower sumac dose, significant decreases in methylation status of three out of five gene promoters-ATM, PTEN, and TIMP3 (PITX2 and RASSF1 promoters were not changed). In vitro evaluations using methanolic extract of R. coriaria showed significant anticancer efficacy in MCF-7 and MDA-MB-231 cells (using Resazurin, cell cycle, annexin V/PI, caspase-3/7, Bcl-2, PARP, and mitochondrial membrane potential analyses). In conclusion, sumac demonstrated significant oncostatic activities in rodent models of breast carcinoma that were validated by mechanistic studies in vivo and in vitro.

Biomedical Research Center Slovak Academy of Sciences 845 05 Bratislava Slovakia

Department of Histology and Embryology Jessenius Faculty of Medicine Comenius University in Bratislava 036 01 Martin Slovakia

Department of Medical Biology Faculty of Medicine P J Šafárik University 040 11 Kosice Slovakia

Department of Medical Biology Jessenius Faculty of Medicine Comenius University in Bratislava 036 01 Martin Slovakia

Department of Microbiology and Immunology Jessenius Faculty of Medicine Comenius University in Bratislava 036 01 Martin Slovakia

Department of Natural Drugs Faculty of Pharmacy Masaryk University 612 42 Brno Czech Republic

Department of Obstetrics and Gynecology Jessenius Faculty of Medicine Comenius University in Bratislava 036 01 Martin Slovakia

Department of Pathology St Elisabeth Oncology Institute 812 50 Bratislava Slovakia

Department of Pharmacology Faculty of Medicine P J Šafárik University 040 11 Košice Slovakia

Division of Oncology Biomedical Center Martin Comenius University in Bratislava Jessenius Faculty of Medicine 036 01 Martin Slovakia

Weill Cornell Medicine in Qatar Qatar Foundation Education City 24144 Doha Qatar

Zobrazit více v PubMed

Heer E., Harper A., Escandor N., Sung H., McCormack V., Fidler-Benaoudia M.M. Global burden and trends in premenopausal and postmenopausal breast cancer: A population-based study. Lancet Glob. Health. 2020;8:e1027–e1037. doi: 10.1016/S2214-109X(20)30215-1. PubMed DOI

Kapinova A., Kubatka P., Golubnitschaja O., Kello M., Zubor P., Solar P., Pec M. Dietary phytochemicals in breast cancer research: Anticancer effects and potential utility for effective chemoprevention. Environ. Health Prev. Med. 2018;23:36. doi: 10.1186/s12199-018-0724-1. PubMed DOI PMC

Uramova S., Kubatka P., Dankova Z., Kapinova A., Zolakova B., Samec M., Zubor P., Zulli A., Valentova V., Kwon T.K., et al. Plant natural modulators in breast cancer prevention: Status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach. EPMA J. 2018;9:403–419. doi: 10.1007/s13167-018-0154-6. PubMed DOI PMC

Liskova A., Koklesova L., Samec M., Varghese E., Abotaleb M., Samuel S.M., Smejkal K., Biringer K., Petras M., Blahutova D., et al. Implications of flavonoids as potential modulators of cancer neovascularity. J. Cancer Res. Clin. Oncol. 2020 doi: 10.1007/s00432-020-03383-8. PubMed DOI

Koklesova L., Liskova A., Samec M., Buhrmann C., Samuel S.M., Varghese E., Ashrafizadeh M., Najafi M., Shakibaei M., Büsselberg D., et al. Carotenoids in Cancer Apoptosis—The Road from Bench to Bedside and Back. Cancers (Basel) 2020;12:2425. doi: 10.3390/cancers12092425. PubMed DOI PMC

Samec M., Liskova A., Koklesova L., Samuel S.M., Zhai K., Buhrmann C., Varghese E., Abotaleb M., Qaradakhi T., Zulli A., et al. Flavonoids against the Warburg phenotype—Concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism. EPMA J. 2020;11:377–398. doi: 10.1007/s13167-020-00217-y. PubMed DOI PMC

Koklesova L., Liskova A., Samec M., Qaradakhi T., Zulli A., Smejkal K., Kajo K., Jakubikova J., Behzadi P., Pec M., et al. Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine. EPMA J. 2020;11:261–287. doi: 10.1007/s13167-020-00210-5. PubMed DOI PMC

Liskova A., Koklesova L., Samec M., Smejkal K., Samuel S.M., Varghese E., Abotaleb M., Biringer K., Kudela E., Danko J., et al. Flavonoids in Cancer Metastasis. Cancers. 2020;12:1498. doi: 10.3390/cancers12061498. PubMed DOI PMC

Vergara D., Simeone P., Bettini S., Tinelli A., Valli L., Storelli C., Leo S., Santino A., Maffia M. Antitumor activity of the dietary diterpene carnosol against a panel of human cancer cell lines. Food Funct. 2014;5:1261–1269. doi: 10.1039/c4fo00023d. PubMed DOI

Mao Y., Hao J., Jin Z.-Q., Niu Y.-Y., Yang X., Liu D., Cao R., Wu X.-Z. Network pharmacology-based and clinically relevant prediction of the active ingredients and potential targets of Chinese herbs in metastatic breast cancer patients. Oncotarget. 2017;8:27007–27021. doi: 10.18632/oncotarget.15351. PubMed DOI PMC

Pourzand A., Tajaddini A., Pirouzpanah S., Asghari-Jafarabadi M., Samadi N., Ostadrahimi A.-R., Sanaat Z. Associations between Dietary Allium Vegetables and Risk of Breast Cancer: A Hospital-Based Matched Case-Control Study. J. Breast Cancer. 2016;19:292–300. doi: 10.4048/jbc.2016.19.3.292. PubMed DOI PMC

Liu X., Lv K. Cruciferous vegetables intake is inversely associated with risk of breast cancer: A meta-analysis. Breast. 2013;22:309–313. doi: 10.1016/j.breast.2012.07.013. PubMed DOI

Fung T.T., Chiuve S.E., Willett W.C., Hankinson S.E., Hu F.B., Holmes M.D. Intake of specific fruits and vegetables in relation to risk of estrogen receptor-negative breast cancer among postmenopausal women. Breast Cancer Res. Treat. 2013;138:925–930. doi: 10.1007/s10549-013-2484-3. PubMed DOI PMC

Apak R., Gorinstein S., Böhm V., Schaich K.M., Özyürek M., Güçlü K. Methods of measurement and evaluation of natural antioxidant capacity/activity (IUPAC Technical Report) Pure Appl. Chem. 2013;85:957–998. doi: 10.1351/PAC-REP-12-07-15. DOI

El Hasasna H., Saleh A., Samri H.A., Athamneh K., Attoub S., Arafat K., Benhalilou N., Alyan S., Viallet J., Dhaheri Y.A., et al. Rhus coriaria suppresses angiogenesis, metastasis and tumor growth of breast cancer through inhibition of STAT3, NFκB and nitric oxide pathways. Sci. Rep. 2016;6:21144. doi: 10.1038/srep21144. PubMed DOI PMC

Abu-Reidah I.M., Ali-Shtayeh M.S., Jamous R.M., Arráez-Román D., Segura-Carretero A. HPLC-DAD-ESI-MS/MS screening of bioactive components from Rhus coriaria L. (Sumac) fruits. Food Chem. 2015;166:179–191. doi: 10.1016/j.foodchem.2014.06.011. PubMed DOI

El Hasasna H., Athamneh K., Al Samri H., Karuvantevida N., Al Dhaheri Y., Hisaindee S., Ramadan G., Al Tamimi N., AbuQamar S., Eid A., et al. Rhus coriaria induces senescence and autophagic cell death in breast cancer cells through a mechanism involving p38 and ERK1/2 activation. Sci. Rep. 2015;5:13013. doi: 10.1038/srep13013. PubMed DOI PMC

Mirian M., Behrooeian M., Ghanadian M., Dana N., Sadeghi-Aliabadi H. Cytotoxicity and antiangiogenic effects of Rhus coriaria, Pistacia vera and Pistacia khinjuk oleoresin methanol extracts. Res. Pharm. Sci. 2015;10:233–240. PubMed PMC

Ghorbani P., Namvar F., Homayouni-Tabrizi M., Soltani M., Karimi E., Yaghmaei P. Apoptotic efficacy and antiproliferative potential of silver nanoparticles synthesised from aqueous extract of sumac (Rhus coriaria L.) IET Nanobiotechnol. 2018;12:600–603. doi: 10.1049/iet-nbt.2017.0080. PubMed DOI PMC

Athamneh K., Hasasna H.E., Samri H.A., Attoub S., Arafat K., Benhalilou N., Rashedi A.A., Dhaheri Y.A., AbuQamar S., Eid A., et al. Rhus coriaria increases protein ubiquitination, proteasomal degradation and triggers non-canonical Beclin-1-independent autophagy and apoptotic cell death in colon cancer cells. Sci. Rep. 2017;7:11633. doi: 10.1038/s41598-017-11202-3. PubMed DOI PMC

Kubatka P., Kello M., Kajo K., Samec M., Jasek K., Vybohova D., Uramova S., Liskova A., Sadlonova V., Koklesova L., et al. Chemopreventive and Therapeutic Efficacy of Cinnamomum zeylanicum L. Bark in Experimental Breast Carcinoma: Mechanistic In Vivo and In Vitro Analyses. Molecules. 2020;25:1399. doi: 10.3390/molecules25061399. PubMed DOI PMC

Kubatka P., Uramova S., Kello M., Kajo K., Samec M., Jasek K., Vybohova D., Liskova A., Mojzis J., Adamkov M., et al. Anticancer Activities of Thymus vulgaris L. in Experimental Breast Carcinoma in Vivo and in Vitro. Int. J. Mol. Sci. 2019;20:1749. doi: 10.3390/ijms20071749. PubMed DOI PMC

Kubatka P., Uramova S., Kello M., Kajo K., Kruzliak P., Mojzis J., Vybohova D., Adamkov M., Jasek K., Lasabova Z., et al. Antineoplastic effects of clove buds (Syzygium aromaticum L.) in the model of breast carcinoma. J. Cell. Mol. Med. 2017;21:2837–2851. doi: 10.1111/jcmm.13197. PubMed DOI PMC

Kubatka P., Kello M., Kajo K., Kruzliak P., Výbohová D., Mojžiš J., Adamkov M., Fialová S., Veizerová L., Zulli A., et al. Oregano demonstrates distinct tumour-suppressive effects in the breast carcinoma model. Eur. J. Nutr. 2017;56:1303–1316. doi: 10.1007/s00394-016-1181-5. PubMed DOI

Kubatka P., Kapinová A., Kello M., Kruzliak P., Kajo K., Výbohová D., Mahmood S., Murin R., Viera T., Mojžiš J., et al. Fruit peel polyphenols demonstrate substantial anti-tumour effects in the model of breast cancer. Eur. J. Nutr. 2016;55:955–965. doi: 10.1007/s00394-015-0910-5. PubMed DOI

Kubatka P., Kello M., Kajo K., Kruzliak P., Výbohová D., Šmejkal K., Maršík P., Zulli A., Gönciová G., Mojžiš J., et al. Young Barley Indicates Antitumor Effects in Experimental Breast Cancer In Vivo and In Vitro. Nutr. Cancer. 2016;68:611–621. doi: 10.1080/01635581.2016.1154577. PubMed DOI

Kubatka P., Kapinová A., Kružliak P., Kello M., Výbohová D., Kajo K., Novák M., Chripková M., Adamkov M., Péč M., et al. Antineoplastic effects of Chlorella pyrenoidosa in the breast cancer model. Nutrition. 2015;31:560–569. doi: 10.1016/j.nut.2014.08.010. PubMed DOI

Choudhari A.S., Mandave P.C., Deshpande M., Ranjekar P., Prakash O. Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice. Front. Pharmacol. 2020;10:1614. doi: 10.3389/fphar.2019.01614. PubMed DOI PMC

Kessler E.R., Su L.-J., Gao D., Torkko K.C., Wacker M., Anduha M., Chronister N., Maroni P., Crawford E.D., Flaig T.W., et al. Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer. Integr. Cancer Ther. 2018;17:1103–1108. doi: 10.1177/1534735418803755. PubMed DOI PMC

Lesinski G.B., Reville P.K., Mace T.A., Young G.S., Ahn-Jarvis J., Thomas-Ahner J., Vodovotz Y., Ameen Z., Grainger E., Riedl K., et al. Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells. Cancer Prev. Res. 2015;8:1036–1044. doi: 10.1158/1940-6207.CAPR-14-0464. PubMed DOI PMC

Pantuck A.J., Leppert J.T., Zomorodian N., Aronson W., Hong J., Barnard R.J., Seeram N., Liker H., Wang H., Elashoff R., et al. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin. Cancer Res. 2006;12:4018–4026. doi: 10.1158/1078-0432.CCR-05-2290. PubMed DOI

Grasselly C., Denis M., Bourguignon A., Talhi N., Mathe D., Tourette A., Serre L., Jordheim L.P., Matera E.L., Dumontet C. The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent. Front. Immunol. 2018;9:2100. doi: 10.3389/fimmu.2018.02100. PubMed DOI PMC

Solár P., Sačková V., Hrčková G., Demečková V., Kassayová M., Bojková B., Mudroňová D., Gancarčíková S., Jendželovský R., Fedoročko P. Antitumor effect of the combination of manumycin A and Immodin is associated with antiplatelet activity and increased granulocyte tumor infiltration in a 4T1 breast tumor model. Oncol. Rep. 2017;37:368–378. doi: 10.3892/or.2016.5265. PubMed DOI

Demečková V., Solár P., Hrčková G., Mudroňová D., Bojková B., Kassayová M., Gancarčiková S. Immodin and its immune system supportive role in paclitaxel therapy of 4T1 mouse breast cancer. Biomed. Pharmacother. 2017;89:245–256. doi: 10.1016/j.biopha.2017.02.034. PubMed DOI

Jeyabalan J., Aqil F., Munagala R., Annamalai L., Vadhanam M.V., Gupta R.C. Chemopreventive and therapeutic activity of dietary blueberry against estrogen-mediated breast cancer. J. Agric. Food Chem. 2014;62:3963–3971. doi: 10.1021/jf403734j. PubMed DOI PMC

Ravoori S., Vadhanam M.V., Aqil F., Gupta R.C. Inhibition of estrogen-mediated mammary tumorigenesis by blueberry and black raspberry. J. Agric. Food Chem. 2012;60:5547–5555. doi: 10.1021/jf205325p. PubMed DOI

Singletary K., MacDonald C., Wallig M. Inhibition by rosemary and carnosol of 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation. Cancer Lett. 1996;104:43–48. doi: 10.1016/0304-3835(96)04227-9. PubMed DOI

Bishayee A., Mandal A., Bhattacharyya P., Bhatia D. Pomegranate exerts chemoprevention of experimentally induced mammary tumorigenesis by suppression of cell proliferation and induction of apoptosis. Nutr. Cancer. 2016;68:120–130. doi: 10.1080/01635581.2016.1115094. PubMed DOI PMC

Cao Y., Himmeldirk K.B., Qian Y., Ren Y., Malki A., Chen X. Biological and biomedical functions of Penta-O-galloyl-D-glucose and its derivatives. J. Nat. Med. 2014;68:465–472. doi: 10.1007/s11418-014-0823-2. PubMed DOI

Kiss A.K., Piwowarski J.P. Ellagitannins, Gallotannins and their Metabolites—The Contribution to the Anti-Inflammatory Effect of Food Products and Medicinal Plants. Curr. Med. Chem. 2018;25:4946–4967. doi: 10.2174/0929867323666160919111559. PubMed DOI

Kapinova A., Stefanicka P., Kubatka P., Zubor P., Uramova S., Kello M., Mojzis J., Blahutova D., Qaradakhi T., Zulli A., et al. Are plant-based functional foods better choice against cancer than single phytochemicals? A critical review of current breast cancer research. Biomed. Pharmacother. 2017;96:1465–1477. doi: 10.1016/j.biopha.2017.11.134. PubMed DOI

Hou Y., Pi C., Feng X., Wang Y., Fu S., Zhang X., Zhao L., Wei Y. Antitumor Activity In Vivo and Vitro of New Chiral Derivatives of Baicalin and Induced Apoptosis via the PI3K/Akt Signaling Pathway. Mol. Ther. Oncol. 2020;19:67–78. doi: 10.1016/j.omto.2020.08.018. PubMed DOI PMC

Abotaleb M., Samuel S., Varghese E., Varghese S., Kubatka P., Liskova A., Büsselberg D. Flavonoids in Cancer and Apoptosis. Cancers. 2018;11:28. doi: 10.3390/cancers11010028. PubMed DOI PMC

Hodroj M.H., Al Bast N. al H.; Taleb, R.I.; Borjac, J.; Rizk, S. Nettle Tea Inhibits Growth of Acute Myeloid Leukemia Cells In Vitro by Promoting Apoptosis. Nutrients. 2020;12:2629. doi: 10.3390/nu12092629. PubMed DOI PMC

Abbaszadeh F., Fakhri S., Khan H. Targeting apoptosis and autophagy following spinal cord injury: Therapeutic approaches to polyphenols and candidate phytochemicals. Pharmacol. Res. 2020;160:105069. doi: 10.1016/j.phrs.2020.105069. PubMed DOI

Gjerdrum C., Tiron C., Høiby T., Stefansson I., Haugen H., Sandal T., Collett K., Li S., McCormack E., Gjertsen B.T., et al. Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc. Natl. Acad. Sci. USA. 2010;107:1124–1129. doi: 10.1073/pnas.0909333107. PubMed DOI PMC

Chen J., Lu L., Feng Y., Wang H., Dai L., Li Y., Zhang P. PKD2 mediates multi-drug resistance in breast cancer cells through modulation of P-glycoprotein expression. Cancer Lett. 2011;300:48–56. doi: 10.1016/j.canlet.2010.09.005. PubMed DOI

Ly J.D., Grubb D.R., Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis. 2003;8:115–128. doi: 10.1023/A:1022945107762. PubMed DOI

Rafi M.M., Vastano B.C. Identification of a structure specific Bcl-2 phosphorylating homoisoflavone molecule from Vietnamese coriander (Polygonatum odoratum) that induces apoptosis and G2/M cell cycle arrest in breast cancer cell lines. Food Chem. 2007;1:332–340. doi: 10.1016/j.foodchem.2006.11.045. DOI

Hyun H.-B., Lee W.S., Go S.-I., Nagappan A., Park C., Han M.H., Hong S.H., Kim G., Kim G.Y., Cheong J., et al. The flavonoid morin from Moraceae induces apoptosis by modulation of Bcl-2 family members and Fas receptor in HCT 116 cells. Int. J. Oncol. 2015;46:2670–2678. doi: 10.3892/ijo.2015.2967. PubMed DOI

Domínguez-López I., Yago-Aragón M., Salas-Huetos A., Tresserra-Rimbau A., Hurtado-Barroso S. Effects of Dietary Phytoestrogens on Hormones throughout a Human Lifespan: A Review. Nutrients. 2020;12:24565. doi: 10.3390/nu12082456. PubMed DOI PMC

Raju S.R., Balakrishnan S., Kollimada S., Chandrashekara K.N., Jampani A. Anti-tumor effects of Artemisia nilagirica extract on MDA-MB-231 breast cancer cells: Deciphering the biochemical and biomechanical properties via TGF-β upregulation. Heliyon. 2020;6:e05088. doi: 10.1016/j.heliyon.2020.e05088. PubMed DOI PMC

Mehraban F., Mostafazadeh M., Sadeghi H., Azizi A., Akbartabar Toori M., Gramizadeh B., Barati V., Sadeghi H. Anticancer activity of Astragalus ovinus against 7, 12 dimethyl benz (a) anthracene (DMBA)-induced breast cancer in rats. Avicenna J. Phytomed. 2020;10:533–545. PubMed PMC

Wang H., Khor T.O., Shu L., Su Z.-Y., Fuentes F., Lee J.-H., Kong A.-N.T. Plants vs. cancer: A review on natural phytochemicals in preventing and treating cancers and their druggability. Anticancer Agents Med. Chem. 2012;12:1281–1305. doi: 10.2174/187152012803833026. PubMed DOI PMC

Niland S., Eble J.A. Neuropilins in the Context of Tumor Vasculature. Int. J. Mol. Sci. 2019;20:639. doi: 10.3390/ijms20030639. PubMed DOI PMC

Hu W.-H., Dai D.K., Zheng B.Z.-Y., Duan R., Dong T.T.-X., Qin Q.-W., Tsim K.W.-K. Piceatannol, a Natural Analog of Resveratrol, Exerts Anti-angiogenic Efficiencies by Blockage of Vascular Endothelial Growth Factor Binding to Its Receptor. Molecules. 2020;25:3769. doi: 10.3390/molecules25173769. PubMed DOI PMC

Liu J., Chen L., Zhang X., Pan L., Jiang L. The Protective Effects of Juglanin in Cerebral Ischemia Reduce Blood–Brain Barrier Permeability via Inhibition of VEGF/VEGFR2 Signaling. Drug Des. Dev. Ther. 2020;14:3165–3175. doi: 10.2147/DDDT.S250904. PubMed DOI PMC

Cho H.-D., Kim J.-H., Park J.-K., Hong S.-M., Kim D.-H., Seo K.-I. Kochia scoparia seed extract suppresses VEGF-induced angiogenesis via modulating VEGF receptor 2 and PI3K/AKT/mTOR pathways. Pharm. Biol. 2019;57:684–693. doi: 10.1080/13880209.2019.1672753. PubMed DOI PMC

Sayır F., Şehitoğulları A., Demir H., Aslan M., Çobanoğlu U., Bilgin C. Serum prolidase activity, total oxidant/antioxidant, and nitric oxide levels in patients with esophageal squamous cell carcinoma. Turk. Gogus Kalp. Damar. Cerrahisi Derg. 2019;27:206–211. doi: 10.5606/tgkdc.dergisi.2019.16888. PubMed DOI PMC

Günes M., Eryilmaz R., Aslan R., Taken K., Demir H., Demir C. Oxidant-antioxidant levels in patients with bladder tumours. Aging Male. 2020:1–6. doi: 10.1080/13685538.2020.1718636. PubMed DOI

Sevastre-Berghian A.C., Ielciu I., Mitre A.O., Filip G.A., Oniga I., Vlase L., Benedec D., Gheldiu A.-M., Toma V.A., Mihart B., et al. Targeting Oxidative Stress Reduction and Inhibition of HDAC1, MECP2, and NF-kB Pathways in Rats With Experimentally Induced Hyperglycemia by Administration of Thymus marshallianus Willd. Extracts. Front. Pharmacol. 2020;11 doi: 10.3389/fphar.2020.581470. PubMed DOI PMC

Eghbaliferiz S., Iranshahi M. Prooxidant Activity of Polyphenols, Flavonoids, Anthocyanins and Carotenoids: Updated Review of Mechanisms and Catalyzing Metals. Phytother. Res. 2016;30:1379–1391. doi: 10.1002/ptr.5643. PubMed DOI

Das P.K., Islam F., Lam A.K. The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma. Cells. 2020;9:1392. doi: 10.3390/cells9061392. PubMed DOI PMC

Yang L., Shi P., Zhao G., Xu J., Peng W., Zhang J., Zhang G., Wang X., Dong Z., Chen F., et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct. Target. Ther. 2020;5:1–35. doi: 10.1038/s41392-020-0110-5. PubMed DOI PMC

Shima H., Yamada A., Ishikawa T., Endo I. Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy? Gland Surg. 2017;6:82–88. doi: 10.21037/gs.2016.08.03. PubMed DOI PMC

Liu T.T., Li X.F., Wang L., Yang J.L. CD133 expressionand clinicopathologic significance in benign and malignant breast lesions. Cancer Biomark. 2020;28:293–299. doi: 10.3233/CBM-190196. PubMed DOI

Rennó A.L., Alves-Júnior M.J., Rocha R.M., De Souza P.C., de Souza V.B., Jampietro J., Vassallo J., Hyslop S., Anhê G.F., de Moraes Schenka N.G., et al. Decreased expression of stem cell markers by simvastatin in 7,12-dimethylbenz(a)anthracene (DMBA)-induced breast cancer. Toxicol. Pathol. 2015;43:400–410. doi: 10.1177/0192623314544707. PubMed DOI

Levi E., Misra S., Du J., Patel B.B., Majumdar A.P.N. Combination of aging and dimethylhydrazine treatment causes an increase in cancer-stem cell population of rat colonic crypts. Biochem. Biophys. Res. Commun. 2009;385:430–433. doi: 10.1016/j.bbrc.2009.05.080. PubMed DOI PMC

Liskova A., Kubatka P., Samec M., Zubor P., Mlyncek M., Bielik T., Samuel S.M., Zulli A., Kwon T.K., Büsselberg D. Dietary Phytochemicals Targeting Cancer Stem Cells. Molecules. 2019;24:899. doi: 10.3390/molecules24050899. PubMed DOI PMC

Naujokat C., McKee D.L. The “Big Five” Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein. Curr. Med. Chem. 2020 doi: 10.2174/0929867327666200228110738. PubMed DOI

Hudlikar R., Wang L., Wu R., Li S., Peter R., Shannar A., Chou P.J., Liu X., Liu Z., Kuo H.-C.D., et al. Epigenetics/epigenomics and prevention of early stages of cancer by isothiocyanates. Cancer Prev. Res. 2020 doi: 10.1158/1940-6207.CAPR-20-0217. PubMed DOI PMC

Li S., Kuo H.-C.D., Yin R., Wu R., Liu X., Wang L., Hudlikar R., Peter R.M., Kong A.-N. Epigenetics/epigenomics of triterpenoids in cancer prevention and in health. Biochem. Pharmacol. 2020;175:113890. doi: 10.1016/j.bcp.2020.113890. PubMed DOI PMC

Samec M., Liskova A., Kubatka P., Uramova S., Zubor P., Samuel S.M., Zulli A., Pec M., Bielik T., Biringer K., et al. The role of dietary phytochemicals in the carcinogenesis via the modulation of miRNA expression. J. Cancer Res. Clin. Oncol. 2019;145:1665–1679. doi: 10.1007/s00432-019-02940-0. PubMed DOI

Jasek K., Kubatka P., Samec M., Liskova A., Smejkal K., Vybohova D., Bugos O., Biskupska-Bodova K., Bielik T., Zubor P., et al. DNA Methylation Status in Cancer Disease: Modulations by Plant-Derived Natural Compounds and Dietary Interventions. Biomolecules. 2019;9:289. doi: 10.3390/biom9070289. PubMed DOI PMC

Xiang T.-X., Yuan Y., Li L.-L., Wang Z.-H., Dan L.-Y., Chen Y., Ren G.-S., Tao Q. Aberrant promoter CpG methylation and its translational applications in breast cancer. Chin. J. Cancer. 2013;32:12–20. doi: 10.5732/cjc.011.10344. PubMed DOI PMC

Wang L.-S., Kuo C.-T., Huang T.H.-M., Yearsley M., Oshima K., Stoner G.D., Yu J., Lechner J.F., Huang Y.-W. Black raspberries protectively regulate methylation of Wnt pathway genes in precancerous colon tissue. Cancer Prev. Res. 2013;6:1317–1327. doi: 10.1158/1940-6207.CAPR-13-0077. PubMed DOI PMC

Huang Y.-W., Gu F., Dombkowski A., Wang L.-S., Stoner G.D. Black raspberries demethylate Sfrp4, a WNT pathway antagonist, in rat esophageal squamous cell papilloma. Mol. Carcinog. 2016;55:1867–1875. doi: 10.1002/mc.22435. PubMed DOI

Romanowska J., Joshi A. From Genotype to Phenotype: Through Chromatin. Genes. 2019;10:76. doi: 10.3390/genes10020076. PubMed DOI PMC

Chatterjee B., Ghosh K., Kanade S.R. Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21CIP1 in human breast cancer cell lines. Biofactors. 2019;45:818–829. doi: 10.1002/biof.1544. PubMed DOI

Royston K., Udayakumar N., Lewis K., Tollefsbol T. A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells. Int. J. Mol. Sci. 2017;18:1092. doi: 10.3390/ijms18051092. PubMed DOI PMC

Samec M., Liskova A., Koklesova L., Mestanova V., Franekova M., Kassayova M., Bojkova B., Uramova S., Zubor P., Janikova K., et al. Fluctuations of Histone Chemical Modifications in Breast, Prostate, and Colorectal Cancer: An Implication of Phytochemicals as Defenders of Chromatin Equilibrium. Biomolecules. 2019;9:829. doi: 10.3390/biom9120829. PubMed DOI PMC

Son S.W., Lee H.Y., Moeng S., Kuh H.J., Choi S.Y., Park J.K. Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals. Molecules. 2020;25:4701. doi: 10.3390/molecules25204701. PubMed DOI PMC

Zou H., Li Y., Liu X., Wu Z., Li J., Ma Z. Roles of plant-derived bioactive compounds and related microRNAs in cancer therapy. Phytother. Res. 2020 doi: 10.1002/ptr.6883. PubMed DOI

Varghese E., Liskova A., Kubatka P., Samuel S.M., Büsselberg D. Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression. Biomolecules. 2020;10:191. doi: 10.3390/biom10020191. PubMed DOI PMC

Wang J., Li Y., Ding M., Zhang H., Xu X., Tang J. Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review) Int. J. Oncol. 2016;50:345–355. doi: 10.3892/ijo.2016.3811. PubMed DOI PMC

Imani S., Zhang X., Hosseinifard H., Fu S., Fu J. The diagnostic role of microRNA-34a in breast cancer: A systematic review and meta-analysis. Oncotarget. 2017;8:23177–23187. doi: 10.18632/oncotarget.15520. PubMed DOI PMC

Venturutti L., Romero L.V., Urtreger A.J., Chervo M.F., Cordo Russo R.I., Mercogliano M.F., Inurrigarro G., Pereyra M.G., Proietti C.J., Izzo F., et al. Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis. Oncogene. 2016;35:2208–2222. doi: 10.1038/onc.2015.281. PubMed DOI

Jung D.E., Park S.B., Kim K., Kim C., Song S.Y. CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway. Sci. Rep. 2017;7:10921. doi: 10.1038/s41598-017-11094-3. PubMed DOI PMC

Kang H. MicroRNA-Mediated Health-Promoting Effects of Phytochemicals. Int. J. Mol. Sci. 2019;20:2535. doi: 10.3390/ijms20102535. PubMed DOI PMC

Kubatka P., Kajo K., Zihlavnikova K., Adamicova K., Vybohova D., Pec M., Nosal V., Stollarova N., Bojkova B., Kassayova M., et al. Immunohistochemical and histomorphological analysis of rat mammary tumors after simvastatin treatment. Neoplasma. 2012;59:516–523. doi: 10.4149/neo_2012_066. PubMed DOI

Aronia melanocarpa L. fruit peels show anti-cancer effects in preclinical models of breast carcinoma: The perspectives in the chemoprevention and therapy modulation

Salvia officinalis L. exerts oncostatic effects in rodent and in vitro models of breast carcinoma

Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells - A potential contribution to the predictive, preventive, and personalized medicine

Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells

Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care

Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles